NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Alliance HealthCare Services, Inc. (NASDAQ: AIQ) (the “Company”, “Alliance”, “we” or “our”), a leading national provider of outsourced radiology, oncology and interventional services, announced today that it has received a letter (the “Expression of Interest”) describing a non-binding proposal from Tahoe Investment Group Co., Ltd. (“Tahoe”), formerly known as Fujian Thai Hot Investment Co., Ltd, to acquire all of the outstanding common shares of Alliance that are not currently owned by THAIHOT Investment Company Limited (“THAIHOT”), an indirect wholly owned subsidiary of Tahoe. Tahoe has proposed a purchase price of $9.60 per share in cash.
As previously disclosed on March 29, 2016, Tahoe, through its subsidiary, completed the purchase of the majority interest in Alliance, owning an aggregate of approximately 52% of outstanding common stock, and entered into a Governance, Voting and Standstill Agreement (the “Governance Agreement”) with the Company.
The Board of Directors of the Company has authorized a Special Committee, comprised solely of directors not affiliated with Tahoe, to evaluate the Expression of Interest. The Special Committee has engaged independent legal counsel and intends to engage an independent financial advisor to assist in its evaluation of the Expression of Interest. In connection with the Expression of Interest, the Special Committee has agreed to waive the provision of the Governance Agreement prohibiting THAIHOT and its affiliates, including Tahoe, from proposing to acquire additional shares of the Company’s common stock. The waiver is for the limited purpose of submitting the Expression of Interest to the Special Committee.
The Expression of Interest indicated that any transaction with Tahoe would be subject to approval by the Special Committee and a non-waiveable condition requiring approval of a majority of the shares of Alliance not owned by Tahoe or is affiliates. Tahoe also indicated that the proposed transaction would not be subject to a financing condition.
About Alliance HealthCare Services
Alliance HealthCare
Services (NASDAQ: AIQ) is a leading national provider of outsourced
healthcare services to hospitals and providers. We also operate
freestanding outpatient radiology, oncology and interventional services
clinics, and Ambulatory Surgical Centers (“ASC”) that are not owned by
hospitals or providers. Diagnostic radiology services are delivered
through the Radiology Division (Alliance HealthCare Radiology),
radiation oncology services are delivered through the Oncology Division
(Alliance Oncology), and interventional and pain management services are
delivered through the Interventional Division (Alliance Interventional).
Alliance is the nation’s largest provider of advanced diagnostic mobile
imaging services, an industry-leading operator of fixed-site imaging
centers, and a leading provider of stereotactic radiosurgery nationwide.
As of September 30, 2016, Alliance operated 619 diagnostic radiology and
radiation therapy systems, including 112 fixed-site radiology centers
across the country, and 32 radiation therapy centers and SRS facilities.
With a strategy of partnering with hospitals, health systems and
physician practices, Alliance provides quality clinical services for
over 1,000 hospitals and other healthcare partners in 45 states, where
approximately 2,400 Alliance Team Members are committed to providing
exceptional patient care and exceeding customer expectations. For more
information, visit www.alliancehealthcareservices-us.com.
About Tahoe
Tahoe is an investment holding company based
in Fuzhou, China, holding a diversified portfolio of assets in various
industries including real estate development, securities, hospitality,
biomedicine and healthcare. Tahoe was founded in 1996 and its total
assets exceeded $13 billion as of December 31, 2015. Tahoe’s diversified
portfolio includes controlling ownership in Thai Hot Group, one of the
leading real-estate developers in China listed on the Shenzhen Stock
Exchange (SZSE:000732). Tahoe is also the third largest shareholder of
the Shanghai Stock Exchange listed Dongxing Securities (SHSE:601198).
Tahoe expanded its business landscape to include biomedicine and
healthcare industry by acquiring a large-scale pharmaceutical company.
In early 2015, Tahoe made healthcare and medical services one of its top
priorities, including radiology and oncology, and it intends to expand
healthcare services in mainland China to an underserved healthcare
marketplace. Qisen Huang is the Founder and Chairman of Tahoe.
Forward-Looking Statements
This press release contains
forward-looking statements that are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements relate to, without limitation, the
Company’s long-term value proposition, growth and international market
and other opportunities. Forward-looking statements can be identified by
the use of forward looking language such as “believe,” “anticipate,”
“expect,” “estimate,” “intend,” “plan,” “project,” “will be,” “will
continue,” “will result,” “could,” “may,” “might,” or any variations of
such words with similar meanings. Readers are cautioned not to place
undue reliance on these forward-looking statements, which speak only as
of the date hereof. These statements involve risks and uncertainties
that could cause actual results to differ materially from those
projected. For a complete list of risks and uncertainties, please refer
to the Risk Factors section of the Company’s Form 10-K for the year
ended December 31, 2015 filed with the Securities and Exchange
Commission.
